S&P 5005,963+0.54%
NASDAQ21,443+0.87%
DOW43,892+0.31%
DAX23,888+0.44%
FTSE 1008,721-0.12%
EUR/USD1.1465+0.07%
GBP/USD1.3220+0.14%
USD/JPY161.31-0.03%
Gold3,241+0.22%
WTI Oil76.40+0.81%
Bitcoin103,241+1.43%
10Y UST4.47%-9bp
S&P 5005,963+0.54%
NASDAQ21,443+0.87%
DOW43,892+0.31%
DAX23,888+0.44%
FTSE 1008,721-0.12%
EUR/USD1.1465+0.07%
GBP/USD1.3220+0.14%
USD/JPY161.31-0.03%
Gold3,241+0.22%
WTI Oil76.40+0.81%
Bitcoin103,241+1.43%
10Y UST4.47%-9bp
MarketsFN
Home/Hedge Fund/BVF Partners/Q4 2021

BVF Partners

Periodo: Q4 2021 Β· Depositato: 2022-02-14
Vedi su SEC EDGAR β†—
AUM
$2.76B
Valore totale del portafoglio
Posizioni
83
Titoli dichiarati
Prima Posizione
GHRS
7.8% $216.4M
Var. Trimestrali
+8 / -3
nuovi Β· usciti
⚠️Informativa sui Depositi 13F

I dati AUM mostrati sono calcolati sommando il valore di mercato dichiarato di tutte le posizioni nei depositi SEC 13F-HR β€” non rappresentano il patrimonio effettivo gestito dal fondo.

  • Escluse liquiditΓ , obbligazioni, private equity, posizioni corte e azioni estere non soggette all'obbligo di dichiarazione.
  • Per le opzioni PUT e CALL, il Valore dichiarato Γ¨ il valore nozionale delle azioni sottostanti β€” non il premio pagato. CiΓ² sovrastima significativamente il capitale effettivamente a rischio.
  • Il patrimonio reale del fondo Γ¨ tipicamente superiore e include strategie, strumenti e posizioni che non compaiono mai in un 13F.
  • I depositi 13F riguardano i gestori istituzionali con β‰₯$100M in titoli 13F. Le posizioni riflettono le partecipazioni a fine trimestre, divulgate entro 45 giorni dalla fine del periodo.

Dati provenienti da SEC EDGAR. Questo tracker Γ¨ a scopo puramente informativo e non costituisce consulenza finanziaria.

Partecipazioni in Portafoglio

Prime 30 posizioni

⚠️ Performance % calcolata dalla data di deposito ( 2022-02-14) si riferisce al titolo sottostante β€” non al P&L del derivato.
TickerEmittenteNozionalePortafoglio %Al DepositoOra (Fine Giornata)Dal DepositoAllocazione
GHRSGH RESEARCH PLC$216.4M7.85%$23.33$27.01+15.8%
7.8%
KYMRKYMERA THERAPEUTICS INC$201.9M7.33%$63.49$113.51+78.8%
7.3%
RCUSARCUS BIOSCIENCES INC$137.5M4.99%$40.47$30.33-25.1%
5.0%
MRUSMERUS N V$131.5M4.77%β€”β€”
4.8%
PTGXPROTAGONIST THERAPEUTICS INC$124.9M4.53%$34.20$131.62+284.9%
4.5%
XENEXENON PHARMACEUTICALS INC$102.8M3.73%$31.24$60.96+95.1%
3.7%
RPTXREPARE THERAPEUTICS INC$102.5M3.72%β€”β€”
3.7%
RLAYRELAY THERAPEUTICS INC$96.1M3.49%$30.71$18.65-39.3%
3.5%
CRNXCRINETICS PHARMACEUTICALS IN$85.3M3.10%$28.41$42.23+48.6%
3.1%
CGEMCULLINAN ONCOLOGY INC$82.8M3.01%$15.43$17.63+14.3%
3.0%
ARGXARGENX SE$75.7M2.75%$350.19$939.68+168.3%
2.8%
XOMAXOMA CORP DEL$73.6M2.67%$20.85$43.00+106.2%
2.7%
OLMAOLEMA PHARMACEUTICALS INC$69.4M2.52%$9.36$12.64+35.0%
2.5%
LKFTGALAPAGOS NV$63.8M2.31%$55.13$30.39-44.9%
2.3%
LXRXLEXICON PHARMACEUTICALS INC$56.6M2.05%$3.94$2.32-41.1%
2.0%
AMRNXXXXAMARIN CORP PLC$55.5M2.01%β€”β€”
2.0%
EQRXEQRX INC$53.6M1.95%β€”β€”
1.9%
SNDXSYNDAX PHARMACEUTICALS INC$46.0M1.67%$21.89$21.82-0.3%
1.7%
RVMDREVOLUTION MEDICINES INC$45.6M1.65%$25.17$189.24+651.9%
1.6%
FDMT4D MOLECULAR THERAPEUTICS IN$44.0M1.60%$21.94$13.00-40.8%
1.6%
EPIXESSA PHARMA INC$40.5M1.47%β€”β€”
1.5%
RAINRAIN THERAPEUTICS INC$38.1M1.38%β€”$1.97
1.4%
VRDNVIRIDIAN THERAPEUTICS INC$37.2M1.35%$19.77$19.40-1.9%
1.4%
RLMDRELMADA THERAPEUTICS INC$37.1M1.35%$22.53$6.28-72.1%
1.4%
VSTMXXXXVERASTEM INC$35.0M1.27%β€”β€”
1.3%
ACIUAC IMMUNE SA$35.0M1.27%$4.95$2.51-49.3%
1.3%
KDNYCHINOOK THERAPEUTICS INC$29.4M1.07%β€”β€”
1.1%
KURAKURA ONCOLOGY INC$28.9M1.05%$14.00$11.10-20.7%
1.1%
TYRATYRA BIOSCIENCES INC$26.4M0.96%$14.07$30.62+117.6%
1.0%
SPROSPERO THERAPEUTICS INC$25.4M0.92%$16.01$2.20-86.3%
0.9%

AttivitΓ  Trimestre su Trimestre

Q4 2021 vs. Q3 2021

Nuove Posizioni (8)

TickerEmittenteNozionaleDal Deposito
MRUSMERUS N V$131.5M
EQRXEQRX INC$53.6M
RLMDRELMADA THERAPEUTICS INC$37.1M-72.1%
KDNYCHINOOK THERAPEUTICS INC$29.4M
CTMXCYTOMX THERAPEUTICS INC$25.1M
PYXSPYXIS ONCOLOGY INC$19.6M
CNCECONCERT PHARMACEUTICALS INC$7.1M
CNTACENTESSA PHARMACEUTICALS PLC$5.1M

Posizioni Chiuse (3)

TickerEmittenteNozionale
MERUS N V$111.3M
GRTSQGRITSTONE BIO INC$16.5M
ANABANAPTYSBIO INC$9.1M

Aumentate (8)

TickerEmittenteNozionaleVar. AzioniDal Deposito
CGEMCULLINAN ONCOLOGY INC$66.3M+630.4%+14.3%
RNACSELECTA BIOSCIENCES INC$4.3M+439.0%
CRNXCRINETICS PHARMACEUTICALS IN$65.3M+214.9%+48.6%
VRDNVIRIDIAN THERAPEUTICS INC$23.9M+133.7%-1.9%
XENEXENON PHARMACEUTICALS INC$78.8M+109.3%+95.1%
RLAYRELAY THERAPEUTICS INC$31.5M+52.8%-39.3%
AMRNXXXXAMARIN CORP PLC$-2.7M+44.3%
CDTXXXXXCIDARA THERAPEUTICS INC$-2.0M+43.6%

Ridotte (8)

TickerEmittenteNozionaleVar. AzioniDal Deposito
ARGXARGENX SE$-34.9M-41.0%+168.3%
RVMDREVOLUTION MEDICINES INC$-22.8M-27.1%+651.9%
INFIQINFINITY PHARMACEUTICALS INC$-14.4M-24.2%
WHWKAADI BIOSCIENCES INC$-12.0M-21.6%
SNDXSYNDAX PHARMACEUTICALS INC$-1.6M-15.6%-0.3%
SPROSPERO THERAPEUTICS INC$-7.9M-12.4%-86.3%
PTGXPROTAGONIST THERAPEUTICS INC$55.8M-6.4%+284.9%
IKNAIKENA ONCOLOGY INC$-0.6M-1.8%
← Torna agli Hedge Fund